FdaApplication
ANDA 212651
Identifiers
- fda_app_no: ANDA212651
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-03-05 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
4 products